시장보고서

상품코드

1841991

불임 검사 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Fertility Testing Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

불임 검사 기기 시장 요약

전 세계 불임 검사 기기 시장 규모는 2024년에 24억 7,000만 달러로 추정되며 2033년에는 47억 1,000만 달러에 달할 것으로 예상되며, 2025년부터 2033년까지 7.50%의 CAGR로 성장할 것으로 예상됩니다. 불임 건강, 출산 지연, 라이프스타일 변화에 대한 인식 증가, 가정용 검사 기기의 기술 발전, 가정 내 비침습적 검사에 대한 선호도 등이 산업 성장을 촉진하는 요인 중 하나입니다.

또한 체외수정(IVF) 및 기타 ART 시술의 증가는 불임 치료 기기를 이용한 임신 전 모니터링을 장려하여 시장 성장을 촉진하고 있습니다. 많은 여성들이 경력 우선순위, 고등교육, 개인적 목표 등을 위해 가정을 갖는 시기를 늦추는 것을 선택하고 있습니다. 생식 능력에 영향을 미칠 수 있기 때문에 생식 관련 건강 상태를 모니터링하는 것에 대한 관심이 높아지고 있습니다.

이 표는 2016년부터 2023년까지 30-34세 및 35세 이상 여성의 초산 비율이 꾸준히 증가하여 산모의 연령이 고령으로 이동하고 있으며, 이는 출산 지연을 강조하고 불임 검사 기기에 대한 수요 증가를 뒷받침하는 것으로 나타났습니다.

출산 지연과 더불어 생활습관 요인도 남녀 모두 생식기능에 큰 영향을 미칩니다. 높은 스트레스 수준, 불규칙한 수면 패턴, 불규칙한 식습관, 신체 활동의 제한, 흡연은 남녀 모두 생식능력을 떨어뜨립니다. 남성의 흡연은 정자 수, 운동성, 정액의 질을 떨어뜨리고, 여성의 흡연은 난소 예비력과 임신율에 영향을 미칩니다. 예를 들어, 금연을 위한 세계행동(Global Action to End Smoking)에 따르면, 2022년 인도에서 15세 이상 약 2억 5,300만 명(남성 2억 2,000만 명, 여성 5,350만 명)이 담배제품을 사용한다고 합니다. 이러한 생활습관 문제로 인해 많은 개인들이 가정용 및 비침습적 불임 검사 기기를 통해 생식 관련 건강 상태를 적극적으로 모니터링하고 있습니다.

또한, 전 세계적으로 불임의 유병률이 증가함에 따라 남녀 모두 불임 검사 기기에 대한 수요가 증가하고 있습니다. 2023년에 발표된 WHO 보고서에 따르면, 전 세계 성인 약 17.5%, 즉 약 6명 중 1명이 불임에 직면하고 있으며, 불임으로 고통받는 사람들을 위해 저렴하고 질 높은 의료 서비스에 대한 접근성을 개선하는 것이 매우 중요하다고 강조하고 있습니다. 그 요인으로는 호르몬 불균형, 여성의 다낭성난소증후군(PCOS) 등 생식기 질환, 남성의 정자 질 저하 등을 꼽을 수 있습니다.

지역별 시장 대시보드
지역별 시장 : 주요 포인트
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진입 기업의 최근 동향과 영향 분석
기업/경쟁 분류
주요 기업의 시장 포지션 분석, 2024년
기업 개요
- viO HealthTech Inc
- Accuquik
- SPD Swiss Precision Diagnostics GmbH
- Tempdrop
- Inito Health Tech Private Limited
- Mira
- YO Home Sperm Test
- Geratherm Medical AG
- bioZhena Corporation
- Eli Health

KSM 25.11.04

Fertility Testing Devices Market Summary

The global fertility testing devices market size was estimated at USD 2.47 billion in 2024 and is expected to reach USD 4.71 billion by 2033, growing at a CAGR of 7.50% from 2025 to 2033. Rising awareness about fertility health, delayed parenthood and lifestyle changes, technological advancements in home testing devices, and preference for at-home and non-invasive testing are some of the factors driving industry growth.

Furthermore, the growth of IVF and other ART procedures encourages pre-conception monitoring using fertility devices, thereby escalating market growth. Many women are choosing to start families later due to career priorities, higher education, and personal goals. Delaying parenthood can affect fertility, leading to increased interest in monitoring reproductive health.

The table shows a clear shift toward older maternal ages, with the proportion of first births among women aged 30-34 and 35+ steadily increasing from 2016 to 2023, highlighting delayed parenthood and supporting the growing demand for fertility testing devices.

In addition to delayed parenthood, lifestyle factors significantly impact reproductive health for both men and women. High stress levels, irregular sleep patterns, poor dietary habits, limited physical activity, and smoking reduce fertility in men and women. Smoking in men has been linked to reduced sperm count, motility, and overall semen quality, while in women, it affects ovarian reserve and conception rates. For instance, as per the Global Action to End Smoking, in 2022, approximately 253.0 million individuals (200.2 million males and 53.5 million females) aged 15 and above were users of tobacco products in India. These lifestyle challenges have led many individuals to actively monitor their reproductive health through home-based and non-invasive fertility testing devices.

Furthermore, the increasing prevalence of infertility worldwide has boosted demand for fertility testing devices for both men and women. A WHO report published in 2023 states that about 17.5% of adults, roughly 1 in 6 people globally, face infertility, emphasizing the critical need for improved access to affordable, high-quality care for those affected. Contributing factors include hormonal imbalances, reproductive conditions like polycystic ovary syndrome (PCOS) in women, and decreasing sperm quality in men.

Global Fertility Testing Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global fertility testing devices market report based on product, application, end-use, and region:

Product Outlook (Revenue, USD Billion, 2021 - 2033)
Ovulation Prediction Kits
Fertility Monitors:
Male Fertility Testing Devices
Application Outlook (Revenue, USD Billion, 2021 - 2033)
Female Fertility Testing
Male Fertility Testing
End-use Outlook (Revenue, USD Billion, 2021 - 2033)
Home Care Settings
Hospitals
Fertility Clinics
Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
  - 1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Fertility Testing Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Delayed parenthood and changing family planning trends
  - 3.2.1.2. Increased prevalence of lifestyle-related fertility issues
  - 3.2.1.3. Growing adoption of at-home fertility testing
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Social Stigma Associated with Fertility Testing
  - 3.2.2.2. Accuracy and Reliability Concerns
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis

Chapter 4. Fertility Testing Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

4.1. Fertility Testing Devices Market: Product Movement Analysis and Market Share
4.2. Fertility Testing Devices Market: Product Segment Dashboard
4.3. Ovulation prediction kits
- 4.3.1. Ovulation prediction kits market, 2021 - 2033 (USD Million)
4.4. Fertility monitors
- 4.4.1. Fertility monitors market, 2021 - 2033 (USD Million)
4.5. Male fertility testing devices
- 4.5.1. Male fertility testing devices market, 2021 - 2033 (USD Million)

Chapter 5. Fertility Testing Devices Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

5.1. Fertility Testing Devices Market: Application Movement Analysis and Market Share
5.2. Fertility Testing Devices Market: Application Segment Dashboard
5.3. Female fertility testing
- 5.3.1. Female fertility testing market, 2021 - 2033 (USD Million)
5.4. Male fertility testing
- 5.4.1. Male fertility testing market, 2021 - 2033 (USD Million)

Chapter 6. Fertility Testing Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

6.1. Fertility Testing Devices Market: End Use Movement Analysis and Market Share
6.2. Fertility Testing Devices Market: End Use Segment Dashboard
6.3. Home care settings
- 6.3.1. Home care settings market, 2021 - 2033 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals market, 2021 - 2033 (USD Million)
6.5. Fertility clinics
- 6.5.1. Fertility clinics market, 2021 - 2033 (USD Million)
6.6. Others
- 6.6.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Fertility Testing Devices Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Regional marketplace: Key takeaways
7.3. North America
- 7.3.1. U.S.
  - 7.3.1.1. Key country dynamics
  - 7.3.1.2. Regulatory framework
  - 7.3.1.3. Competitive scenario
  - 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.3.2. Canada
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.3.3. Mexico
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Billion)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Regulatory framework
  - 7.4.1.3. Competitive scenario
  - 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.2. Germany
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.3. France
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.4. Italy
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework
  - 7.4.4.3. Competitive scenario
  - 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.5. Spain
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework
  - 7.4.5.3. Competitive scenario
  - 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.6. Norway
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework
  - 7.4.6.3. Competitive scenario
  - 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.7. Sweden
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework
  - 7.4.7.3. Competitive scenario
  - 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.8. Denmark
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework
  - 7.4.8.3. Competitive scenario
  - 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.2. China
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.3. India
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.4. Australia
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.5. South Korea
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.6. Thailand
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Billion)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.6.2. Argentina
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
7.7. Middle East & Africa
- 7.7.1. South Africa
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7.3. UAE
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7.4. Kuwait
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market position analysis, 2024
8.4. Company Profiles
- 8.4.1. viO HealthTech Inc
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Accuquik
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. SPD Swiss Precision Diagnostics GmbH
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. Tempdrop
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Inito Health Tech Private Limited
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. Mira
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. YO Home Sperm Test
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Geratherm Medical AG
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. bioZhena Corporation
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Eli Health
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

불임 검사 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Fertility Testing Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

불임 검사 기기 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 불임 검사 기기 시장 변수, 동향, 범위

제4장 불임 검사 기기 시장, 제품별, 2021-2033년

제5장 불임 검사 기기 시장, 용도별, 2021-2033년

제6장 불임 검사 기기 시장, 최종 용도별, 2021-2033년

제7장 불임 검사 기기 시장 : 지역별 추정·동향 분석